VERU INC. Income Taxes Paid
VERU INC. (VERU) reported Income Taxes Paid of $78.55 thousand for the 12-month period ending 2025-09-30, per its 10-K filed 2025-12-17.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2025-12-17
- VERU INC. income taxes paid, net for the quarter ending 2013-03-31 was $105.27K, a 140.15% increase year-over-year.
- VERU INC. income taxes paid, net for the quarter ending 2012-12-31 was $25.68K, a 90.47% decline year-over-year.
- VERU INC. income taxes paid, net for the quarter ending 2012-06-30 was $261.33K, a 3035.28% increase year-over-year.
- VERU INC. income taxes paid, net for the quarter ending 2012-03-31 was $43.84K, a 482.93% increase year-over-year.
- VERU INC. income taxes paid, net for fiscal 2025 was $78.55K, a 78.70% decline from fiscal 2024.
- VERU INC. income taxes paid, net for fiscal 2024 was $368.82K, a 49.10% increase from fiscal 2023.
- VERU INC. income taxes paid, net for fiscal 2023 was $247.36K, a 41.40% decline from fiscal 2022.
- VERU INC. income taxes paid, net for fiscal 2022 was $422.13K, a 69.71% increase from fiscal 2021.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 12 month |
|---|---|---|---|---|
| 2025-09-30 | $78.55K 10-K · filed 2025-12-17 | |||
| 2024-09-30 | $368.82K 10-K · filed 2025-12-17 | |||
| 2023-09-30 | $247.36K 10-K · filed 2024-12-16 | |||
| 2022-09-30 | $422.13K 10-K/A · filed 2024-04-01 | |||
| 2021-09-30 | $248.75K 10-K · filed 2022-12-05 | |||
| 2020-09-30 | $362.06K 10-K · filed 2021-12-02 | |||
| 2019-09-30 | $303.58K 10-K · filed 2020-12-10 | |||
| 2018-09-30 | $222.22K 10-K · filed 2019-12-12 | |||
| 2013-03-31 | $105.27K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-05-02 | $130.95K 10-Q · filed 2013-05-02 | ||
| 2012-12-31 | $25.68K 10-Q · filed 2013-01-30 | |||
| 2012-06-30 | $261.33K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-07-31 | $305.16K derived: sum of 2 quarters · filed 2013-05-02 | $574.55K 10-Q · filed 2012-07-31 | $607.74K derived: sum of 4 quarters · filed 2013-05-02 |
| 2012-03-31 | $43.84K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-05-02 | $313.22K 10-Q · filed 2013-05-02 | $346.42K derived: sum of 3 quarters · filed 2013-05-02 | $354.75K derived: sum of 4 quarters · filed 2013-05-02 |
| 2011-12-31 | $269.38K 10-Q · filed 2013-01-30 | $302.58K derived: sum of 2 quarters · filed 2013-01-30 | $310.92K derived: sum of 3 quarters · filed 2013-01-30 | $318.44K derived: sum of 4 quarters · filed 2013-01-30 |
| 2011-09-30 | $33.20K derived: 10-K 12 month − 10-Q 9 month · filed 2011-12-02 | $41.53K derived: sum of 2 quarters · filed 2012-07-31 | $49.05K derived: sum of 3 quarters · filed 2012-07-31 | $57.15K 10-K · filed 2011-12-02 |
| 2011-06-30 | $8.34K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-07-31 | $15.86K derived: sum of 2 quarters · filed 2012-07-31 | $23.95K 10-Q · filed 2012-07-31 | $31.95K derived: sum of 4 quarters · filed 2012-07-31 |
| 2011-03-31 | $7.52K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-05-01 | $15.62K 10-Q · filed 2012-05-01 | $23.61K derived: sum of 3 quarters · filed 2012-05-01 | |
| 2010-12-31 | $8.10K 10-Q · filed 2012-01-31 | $16.09K derived: sum of 2 quarters · filed 2012-01-31 | ||
| 2010-09-30 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2011-12-02 | $111.93K 10-K · filed 2011-12-02 | ||
| 2010-06-30 | $103.93K 10-Q · filed 2011-08-05 | |||
| 2009-09-30 | $133.91K 10-K · filed 2011-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |